Gender-based differences in mortality in response to high product ratio massive transfusion

Susan E. Rowell, Ronald R. Barbosa, Carrie E. Allison, Philbert Y. Van, Martin A. Schreiber, Trauma Outcomes Group The Trauma Outcomes Group

    Research output: Contribution to journalArticlepeer-review

    27 Scopus citations


    Background: Recent data suggest that patients undergoing massive transfusion have lower mortality rates when ratios of plasma and platelets to red blood cells (RBCs) of ≥1:2 are used. This has not been examined independently in women and men. A gender dichotomy in outcome after severe injury is known to exist. This study examined gender-related differences in mortality after high product ratio massive transfusion. Methods: A retrospective study was conducted using a database containing massively transfused trauma patients from 23 Level I trauma centers. Baseline demographic, physiologic, and biochemical data were obtained. Univariate and logistic regression analyses were performed. Adjusted mortality in patients receiving high (≥1:2) or low (<1:2) ratios of plasma or platelets to RBCs was compared in women and men independently. Results: Seven hundred four patients were analyzed. In males, mortality was lower for patients receiving a high plasma:RBC ratio at 24 hours (20.6% vs. 33.0% for low ratio, p = 0.005) and at 30 days (34.9% vs. 42.8%, p = 0.032). Males receiving a high platelet:RBC ratio also had lower 24-hour mortality (17.6% vs. 31.5%, p = 0.004) and 30-day mortality (32.1% vs. 42.2%, p = 0.045). Females receiving high ratios of plasma or platelets to RBCs had no improvement in 24-hour mortality (p = 0.119 and 0.329, respectively) or 30-day mortality (p = 0.199 and 0.911, respectively). Use of high product ratio transfusions did not affect 24-hour RBC requirements in males or females. Conclusion: Use of high plasma:RBC or platelet:RBC ratios in massive transfusion may benefit men more than women. This may be due to gender-related differences in coagulability. Further study is needed to determine whether separate protocols for women and men should be established.

    Original languageEnglish (US)
    Pages (from-to)S375-S379
    JournalJournal of Trauma - Injury, Infection and Critical Care
    Issue number2 SUPPL. 3
    StatePublished - Aug 1 2011


    • Gender
    • Massive transfusion
    • Mortality
    • Trauma

    ASJC Scopus subject areas

    • Surgery
    • Critical Care and Intensive Care Medicine


    Dive into the research topics of 'Gender-based differences in mortality in response to high product ratio massive transfusion'. Together they form a unique fingerprint.

    Cite this